Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control

Oral Oncology

Volumn 36, Issue 3, 2000, Pages 256-263

  Scully, C ^a   Field, J K ^b,c   Tanzawa, H ^d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c Roy Castle International Centre for Lung Cancer Research   (United Kingdom)

^d CHIBA UNIVERSITY   (Japan)

Author keywords

Cancer; Chromosomes; Genetics; Oral

Indexed keywords

ACETALDEHYDE; ACYLTRANSFERASE; ALCOHOL; ALCOHOL DEHYDROGENASE; AROMATIC AMINE; CARCINOGEN; CYCLINE; CYTOCHROME P450; DNA; EPOXIDE HYDROLASE; GENE PRODUCT; GLUTATHIONE TRANSFERASE; HALIDE; MUTAGENIC AGENT; NITROSAMINE; PHOSPHOTRANSFERASE; POLYCYCLIC AROMATIC HYDROCARBON; PROTEIN P21; PROTEIN P27; PROTEIN P53; SULFOTRANSFERASE; TELOMERASE; URETHAN;

ARTICLE; CELL CYCLE; CHROMOSOME; DNA DAMAGE; DNA REPAIR; GENE; HEAD AND NECK CARCINOMA; HUMAN; LIFESTYLE; METABOLISM; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTO ONCOGENE; SQUAMOUS CELL CARCINOMA; TOBACCO;

ALCOHOL DRINKING; AMINES; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; DNA DAMAGE; DNA REPAIR; GENETIC PREDISPOSITION TO DISEASE; HEAD AND NECK NEOPLASMS; HUMANS; PLANTS, TOXIC; TELOMERASE; TOBACCO;

EID: 0034192040     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(00)00007-5     Document Type: Article

References (57)

1. Begg C.B., Zhang Z.F., Sun M., Herr H.W., Schantz S.P. Methodology for evaluating incidence of second primary cancers with application to smoking-related cancers from SEER. Am J Epidemiol. 142:1995;653-665.
2. Trizna Z., Schantz S.P. Hereditary and environmental factors associated with risk and progression of head and neck cancer. Otolaryngol Clin North Am. 25:1992;1089-1103.
3. Park J.Y., Muscat J.E., Ren Q., Schantz S.P., Harwick R.D., Stern J.C., Pike V., Richie J.P., Lazarus P. CYP1A1 and GSTM1 polymorphisms and oral cancer risk. Cancer Epidemiol Biomarkers Prey. 6:1997;791-797.
4. Yokoyama A., Muramatsu T., Ohmori T., Makuuchi H., Higuchi S., Matsushita S.et al. Multiple primary esophageal and concurrent upper aerodigestive tract cancer and the aldehyde dehydrogenase-2 genotype of Japanese alcoholics. Cancer. 77:1996;1986-1990.
5. Coutelle C., Ward P.J., Fleury B., Quattrocchi P., Chambrin H., Iron A., Couzigou P., Cassaigne A. Laryngeal and oropharyngeal cancer, alcohol dehydrogenase 3 and glutathione S-transferase M1 polymorphisms. Hum Genet. 99:1997;319-325.
6. Harty L.C., Caporaso N.E., Hayes Rb., Winn D.M., Bravo-Otero E., Blot W.J.et al. Alcohol dehydrogenase 3 genotype and risk of oral cavity and pharyngeal cancers. JNCI. 89:1997;1698-1705.
7. Kawajiri K., Fujii-Kuriyama Y. P450 and human cancer. Jpn J Cancer Res. 82:1991;1325-1335.
8. Janot F., Massaad L., Ribrag V., de Waziers I., Beaune P.H., Luboinski B., Parise O., Gouyette A., Chabot G.G. Principal xenobiotic-metabolising enzyme systems in human head and neck squamous cell carcinoma. Carcinogenesis. 14:1993;1279-1283.
9. Hung H.G., Chuang J., Chien Y.C., Chern H.D., Chiang C.P., Huo Y.S., Hildesheim A., Chen C.J. Genetic polymorphisms of CYP2E1, GSTM1 and GSTT1; environmental factors and risk of oral cancer. Cancer Epidemiol. 6:1997;901-905.
10. Ophuis M.B.O., van Lieshout E.M.M., Roelofs H.M.J., Peters W.H.M., Manni J.J. Glutathione S transferase Ml and T1 and cytochrome p4501A1 polymorphisms in relation to the risk for benign and malignant head and neck lesions. Cancer. 82:1998;936-943.
11. Mulder T.P.J., Manni J.J., Roelofs H.M.J., Peters H.M., Wiersma A. Glutathione S transferases and glutathione in human head and neck cancer. Carcinogenesis. 16:1995;619-624.
12. Jahnke V., Matthias C., Bockmuhl U., Strange R.C. Genetic predisposition for the development of head and neck carcinomas. Laryngorhinootologie. 78:1999;24-27.
13. Lazarus P., Sheikh S.N., Ren Q., Schantz S.P., Stern J., Richie J.P., Park J.Y. P53 but not p16 mutations in oral tumors are associated with specific CYP1A1 and GSTM1 polymorphic genotypes and tobacco use. Carcinogenesis. 19:1998;509-514.
14. Mathias C., Bockmuhl U., Jahnke V., Harries L.W., Wolf C.R., Jones P.W., Alldersea J., Worrall S.F., Hand P., Fryer A.A., Strange R.C. The glutathione S-transferase GSTP1 polymorphism: effects on susceptibility to oral/pharyngeal and laryngeal carcinomas. Pharmacogenetics. 8:1998;1-6.
15. Trizna Z., Clayman G.L., Spitz M.R., Briggs K.L., Goepfert H. Glutathione S transferase genotype as a risk factor for head and neck cancer. Am J. Surg. 170:1995;499-501.
16. Katoh T., Kaneko S., Kohshi K., Munaka M., Kitagawa K., Kunugita N., Ikemura K., Kawamoto T. Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and oral cavity cancer. lnt J. Cancer. 83:1999;606-609.
17. Sato M., Sato T., Izumo T., Amagasa T. Genetic polymorphism of drug-metabolising enzymes and susceptibility to oral cancer. Carcinogenesis. 20:1999;1927-1931.
18. Deakin M., Elder J., Hendrickse C., Peckham D., Baldwin D., Pantin C., Wild N., Leopard P., Bell D.A., Jones P., Duncan H., Brannigan K., Alldersea J., Fryer A.A., Strange R.C. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GTSM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis. 17:1996;881-884.
19. Tanimoto K., Hayashi S.I., Yoshiga K., lchikawa T. Polymorphisms of the CYP1A1 and GSTM1 gene involved in oral squamous cell carcinoma in association with a cigarette dose. Oral Oncology. 35:1999;191-196.
20. Nair U.J., Nair J., Mathew B., Bartsch H. Glutathione-S-transferase Ml and Ti null genotypes as risk factors for oral leukoplakia in ethnic Indian betel quid/tobacco chewers. Carcinogenesis. 20:1999;743-748.
21. Katoh T., Kaneko S., Boissy R., Watson M., Ikemura K., Bell D.A. A pilot study testing the association between N-acetyl transferases 1 and 2 and risk of oral squamous cell carcinoma in Japanese people. Carcinogenesis. 19:1998;1803-1807.
22. Adhvaryu S.G., Dave B.J., Trivedi A.H. Cytogenetic, surveillance of tobacco-areca nut (mava) chewers, including patients with oral cancers and premalignant conditions. Mutat Res. 261:1991;41-49.
23. Bazopoulou-Kyrkanidou E., Garas J., Angelopoulos A.P. SGE in lymphocytes of patients with oral carcinoma. Cancer Genet Gytogenet. 20:1986;35-38.
24. Trivedi A.H., Bhavana J.D., Adhvaryu S.G. Monitoring of smokeless tobacco consumers using cytogenetic endpoints. Anticancer Res. 13:1993;2245-2250.
25. Popp W., Schell C., Kraus R., Vahrenholz C., Wolf R., Radtke J., Bierwirth K., Norpoth K. DNA strand breakage and DNA adducts in lymphocytes of oral cancer patients. Carcinogenesis. 14:1993;2251-2256.
26. Popp W., Wolf R., Vahrenholz C., Radtke J., Schell C., Kraus R., Brauksiepe, Norpoth K. Sister chromatid exchange frequencies in lymphocytes of oral cancer patients seem to be influenced by drinking habits. Carcinogenesis. 15:1994;1603-1607.
27. Cloos J., Braakhuis B.J.M., Steen I., Copper M.P., De Vries N., Nauta J.J.P., Snow G.B. Increased mutagen sensitivity in head-and-neck squamous-cell carcinoma patients, particularly those with multiple primary tumors. Int. J. Cancer. 56:1994;816-819.
28. Cloos J., Spitz M.R., Schantz S.P.et al. Genetic susceptibility to head and neck squamous cell carcinoma. J. Natl. Cancer Inst. 88:1996;530-535.
29. Spitz M.R., Fueger J.J., Beddingfield N.A., Annegers J.F., Hsu T.C., Newell G.R., Schantz S.P. Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancers. Cancer Res. 49:1989;4626-4628.
30. Spitz M.R., Fueger J.J., Halabi S., Schantz S.P., Sample D., Hsu T.C. Mutagen sensitivity in upper aerodigestive tract cancer: a case-control analysis. Cancer Epidemiol Biomarkers Prev. 2:1993;329-333.
31. Pandita T.K., Hittleman W.N. Evidence of a chromatin basis for increased mutagen sensitivity associated with multiple primary malignancies of the head and neck. Int. J. Cancer. 61:1995;738-743.
32. Schantz S.P., Spitz M.R., Hsu T.C. Mutagen sensitivity in patients with head and neck cancers: a biologic marker for risk of multiple primary malignancies. J. Natl. Cancer Inst. 82:1990;1773-1775.
33. Bondy M.L., Spitz M.R., Halibi S.et al. Association between family history of cancer and mutagen sensitivity in upper aerodigestive tract cancer patients. Cancer Epidemiol Biomarkers Prey. 2:1993;103-106.
34. Gallo O., Bianchi S., Giovannucci-Uzzzielli M.L., Santoro R., Lenzi S., Salimbeni S., Abbruzzese M., Alajmo E. p53 oncoprotein overexpression correlates with mutagen-induced chromosome fragility in head and neck cancer patients with multiple malignancies. Brit J. Cancer. 71:1995;1008-1012.
35. Wand L.E., Sturgis E.M., Eicher S.A., Spitz M.R., Hong W.K., Wei Q. Mutagen sensitivity to benzo (α) pyrene diol epoxide and the risk of squamous cell carcinoma of the head and neck. Clin Cancer Res. 4:1998;1773-1778.
36. Freidberg E.C. DNA repair. 1985;Freedman and Company, New York.
37. Mao L., Lee J.S., Fan Y.H., Ro J.Y., Batsakis J.G., Lippman S., Hittleman W., Hong W.K. Frequent microsatellite alterations at chromosomes 9p2l and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nature Medicine. 2:1996;682-685.
38. Field J.K. Genomic instability in squamous cell carcinoma of the head and neck. Anticancer Res. 16:1996;2421-2431.
39. Piccinin S., Gasparotto D., Vukosavljevic T., Barzan L., Sulfaro S., Maestro R., Boiocchi M. Microsatellite instability in squamous cell carcinoma of the head and neck related to field cancerisation phenomena. Br. J. Cancer. 78:1998;1147-1151.
40. Nunn J., Scholes A.G.M., Liloglou T., Fear S., Jones A.S., Vaughan E.D., Gosney J.R., Field J.K. Fractional allele loss data indicates distinct genetic populations in the development of squamous cell carcinoma of the head and neck (SCCHN). Carcinogenesis. 12:1999;2219-2228.
41. Roz L., Wu C.L., Porter S.R., Scully C.et al. Allelic imbalance on chromosome 3p in oral dysplastic lesions: an early event in oral carcinogenesis. Cancer Res. 56:1996;1228-1231.
42. Rowley H., Jones A., Spandidos D., Field J. Definition of a tumour suppressor gene locus on the short arm of chromosome 3 in squamous cell carcinoma of the head and neck by means of microsatellite markers. Arch Otolaryngol Head Neck Surg. 122:1996;497-501.
43. lshwad C.S., Ferrell R.E., Rossie K.M.et al. Microsatellite instability in oral cancer. Int. J. Cancer. 64:1995;332-335.
44. Kiaris H., Spandidos D.A., Jones A.S., Field J.K. Loss of heterozygosity and microsatellite instability of the H-ras gene in cancer of the head and neck. Int. J. Oncol. 5:1994;579-582.
45. Wei Q., Eicher S.A., Guan Y., Cheng L., Xu J., Young L.N., Saunders K.G., Jiang H., Hong W.K., Spitz M.R., Strom S.S. Reduced expression of hMLH1 and hGTBP/hMSH6: a risk factor for head and neck cancer. Cancer Epidemiol Biomarker Prey. 7:1998;309-314.
46. LoMuzio L., Nocini P., Mignogna M.D., Pannone G., Staibano S., Procaccini H., Mariggio M.A., Dolci M., DeRosa G. Immunocytochemical detection of hMSH2 and HMLH1 expression in oral SGG. Anticancer Res. 19:1999;933-940.
47. Sturgis E.M., Castillo E.J., Li L., Zheng R., Eicher S.A., Clayman G.L., Strom S.S., Spitz M.R., Wei Q. Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis. 20:1999;2125-2129.
48. Gheng L., Eicher S.A., Guo Z., Hong W.K., Spitz M.R., Wei Q. Reduced DNA repair capacity in head and neck capacity in head and neck cancer patients. Cancer Epidemiol. Biomarkers Prey. 7:1998;465-468.
49. Yanagisawa T., Urade M., Yamamoto Y., Furuyama J. Increased expression of human DNA repair genes, XRGC1, XRCG3, and RAD51, in radioresistant human KB carcinoma cell line N10. Oral Oncology. 34:1998;524-528.
50. Wei Q., Spitz M.R., Gu J., Cheng L., Xu X., Strom S.S., Kripke M.L., Hsu T.C. DNA repair capacity correlates with mutagen sensitivity in lymphoblastoid cell lines. Cancer Epidemiol Biomarkers Prey. 5:1996;199-204.
51. Yu G.P., Zhang Z.F., Hsu T.C., Spitz M.R., Schantz S.P. Family history of cancer, mutagen sensitivity, and increased risk of head and neck cancer. Cancer Lett. 146:1999;93-101.
52. Todd R., Wong D.T.W. Epidermal growth factor receptor (EGFR) biology and human oral cancer. Histol. Histopathol. 14:1999;491-500.
53. Schoelch M. Cell cycle proteins and the development of oral squamous cell carcinoma. Oral Oncology. 35:1999;333-342.
54. Roberts J.M. Evolving ideas about cyclins. Cell. 98:1999;129-132.
55. Chen X. The p53 family: same response, different signals? Mol Med Today. 5:1999;387-392.
56. Kanekawa A., Tsuji T., Oga A., Sasaki K., Shinozaki F. Chromosome 17 abnormalities in squamous cell carcinoma of the oral cavity, and its relationship with p53 and BcI-2 expression. Anticancer Res. 19:1999;81-86.
57. Pardue M.L., DeBaryshe P.G. Telomeres and telomerase: more than the end of the line. Chromosoma. 108:1999;73-82.